Research tools
Analyst Ratings Screener
Find recent upgrades, downgrades, initiations, and reiterations by firm, rating, consensus, target upside, sector, and company size.
Save your best screens
Sign in to keep filters and sorting ready for your next visit.
9,027 matching rating changes
Export CSV| Date, sort lowest first | Symbol | Company | Firm | Action | Prior rating | New rating | Consensus | Analysts, sort highest first | Avg. target | Target upside, sort highest first | Market cap, sort highest first |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | GOSS | Gossamer Bio, Inc. | Piper Sandler | Main | Overweight | Overweight | Buy | 15 | $9.00 | -19.93% | 824.25M |
| Nov 11, 2026 | GOSS | Gossamer Bio, Inc. | Wedbush | Main | Neutral | Neutral | Buy | 15 | $9.00 | -19.93% | 824.25M |
| Nov 11, 2026 | GPN | Global Payments Inc. | Bernstein | Main | Market Perform | Market Perform | Hold | 35 | $100.33 | +13.77% | 20.1B |
| Nov 11, 2026 | GWRE | Guidewire Software, Inc. | Jefferies | Initiated | — | Hold | Buy | 21 | $275.00 | +71.86% | 17.39B |
| Nov 11, 2026 | HALO | Halozyme Therapeutics, Inc. | Morgan Stanley | Downgrade | Overweight | Equal-Weight | — | — | $73.83 | -26.66% | 7.28B |
| Nov 11, 2026 | HBIO | Harvard Bioscience, Inc. | StoneX | Downgrade | Speculative Buy | Hold | — | — | $7.00 | -24.04% | 33.49M |
| Nov 11, 2026 | HIG | The Hartford Insurance Group, Inc. | Wells Fargo | Downgrade | Overweight | Equal-Weight | — | — | $150.29 | +9.78% | 37.7B |
| Nov 11, 2026 | HR | Healthcare Realty Trust Incorporated | UBS | Main | Neutral | Neutral | Hold | 20 | $20.33 | +6.11% | 6.1B |
| Nov 11, 2026 | HROW | Harrow Health, Inc. | BTIG | Reiterated | Buy | Buy | — | — | $73.00 | +157.95% | 1.89B |
| Nov 11, 2026 | HROWL | Harrow Health, Inc. 8.625% Senior Notes due 2026 | BTIG | Reiterated | Buy | Buy | — | — | — | — | 1.37B |
| Nov 11, 2026 | HROWM | Harrow Health, Inc. 11.875% Senior Notes due 2027 | BTIG | Reiterated | Buy | Buy | Buy | 14 | $34.93 | +34.21% | 1.34B |
| Nov 11, 2026 | HTH | Hilltop Holdings Inc. | Piper Sandler | Main | Neutral | Neutral | Hold | 11 | $36.00 | -0.28% | 2.23B |
| Nov 11, 2026 | HUBB | Hubbell Incorporated | JP Morgan | Main | Neutral | Neutral | — | — | $487.75 | +11.36% | 24.6B |
| Nov 11, 2026 | HUM | Humana Inc. | TD Cowen | Main | Hold | Hold | — | — | $293.17 | -33.93% | 32B |
| Nov 11, 2026 | HUMA | Humacyte, Inc. | Barclays | Main | Equal-Weight | Equal-Weight | — | — | $4.17 | +600.37% | 187.81M |
| Nov 11, 2026 | INO | Inovio Pharmaceuticals, Inc. | Piper Sandler | Reiterated | Overweight | Overweight | Buy | 10 | $6.00 | +310.96% | 114.68M |
| Nov 11, 2026 | IRD | Opus Genetics, Inc. | RBC Capital | Main | Outperform | Outperform | — | — | $7.00 | +72.41% | 167.86M |
| Nov 11, 2026 | IRD | Opus Genetics, Inc. | HC Wainwright & Co. | Main | Buy | Buy | — | — | $7.00 | +72.41% | 167.86M |
| Nov 11, 2026 | IRTC | iRhythm Technologies, Inc | Stephens & Co. | Main | Overweight | Overweight | — | — | $210.80 | +125.31% | 5.45B |
| Nov 11, 2026 | JBI | Janus International Group, Inc. | Keybanc | Main | Overweight | Overweight | Buy | 9 | $9.25 | +146.67% | 942.62M |
| Nov 11, 2026 | JBTM | JBT Marel Corporation | Jefferies | Initiated | — | Hold | — | — | $174.50 | +39.41% | 8.09B |
| Nov 11, 2026 | JRSH | Jerash Holdings (US), Inc. | DA Davidson | Main | Buy | Buy | — | — | $3.50 | -52.38% | 39.5M |
| Nov 11, 2026 | KIM | Kimco Realty Corporation | UBS | Main | Buy | Buy | Hold | 29 | $25.33 | -0.51% | 13.64B |
| Nov 11, 2026 | KKR | KKR & Co. Inc. | Piper Sandler | Main | Overweight | Overweight | Buy | 13 | $162.00 | +66.67% | 127.24B |
| Nov 11, 2026 | KLRS | Kalaris Therapeutics Inc | Citizens | Main | Market Outperform | Market Outperform | — | — | $3.00 | +80.72% | 157.29M |
| Nov 11, 2026 | KRG | Kite Realty Group Trust | UBS | Main | Neutral | Neutral | — | — | $25.00 | -2.69% | 5.07B |
| Nov 11, 2026 | KRMD | KORU Medical Systems, Inc. | Piper Sandler | Reiterated | Neutral | Neutral | Buy | 11 | $3.25 | -11.92% | 271.03M |
| Nov 11, 2026 | KSPI | Joint Stock Company Kaspi.kz | Freedom Broker | Main | Hold | Hold | — | — | $111.00 | +25.23% | 14.66B |
| Nov 11, 2026 | LCID | Lucid Group, Inc. | Citigroup | Main | Buy | Buy | — | — | $16.00 | +391.55% | 3.87B |
| Nov 11, 2026 | LEGN | Legend Biotech Corporation | RBC Capital | Main | Outperform | Outperform | Buy | 24 | $60.67 | +227.24% | 2.12B |
| Nov 11, 2026 | LEGN | Legend Biotech Corporation | Barclays | Main | Overweight | Overweight | Buy | 24 | $60.67 | +227.24% | 2.12B |
| Nov 11, 2026 | LEGN | Legend Biotech Corporation | Morgan Stanley | Main | Overweight | Overweight | Buy | 24 | $60.67 | +227.24% | 2.12B |
| Nov 11, 2026 | LEGN | Legend Biotech Corporation | Oppenheimer | Main | Perform | Perform | Buy | 24 | $60.67 | +227.24% | 2.12B |
| Nov 11, 2026 | LFUS | Littelfuse, Inc. | Jefferies | Initiated | — | Buy | — | — | $310.00 | -21.84% | 6.75B |
| Nov 11, 2026 | LGND | Ligand Pharmaceuticals Incorporated | Barclays | Main | Overweight | Overweight | — | — | $245.33 | -22.43% | 3.6B |
| Nov 11, 2026 | LGNDZ | Ligand Pharmaceuticals, Inc. | Barclays | Main | Overweight | Overweight | Buy | 13 | — | — | 157.46K |
| Nov 11, 2026 | LGNXZ | Ligand Pharmaceuticals, Inc. | Barclays | Main | Overweight | Overweight | Buy | 13 | — | — | 23.62K |
| Nov 11, 2026 | LGNYZ | Ligand Pharmaceuticals Incorporated | Barclays | Main | Overweight | Overweight | Buy | 13 | — | — | 885.69K |
| Nov 11, 2026 | LIFX | Life360, Inc. | Citigroup | Main | Buy | Buy | — | — | — | — | 6B |
| Nov 11, 2026 | LIFX | Life360, Inc. | B of A Securities | Downgrade | Buy | Neutral | — | — | — | — | 6B |
| Nov 11, 2026 | LINE | Lineage, Inc. | Evercore ISI Group | Main | In-Line | In-Line | — | — | $43.44 | +24.36% | 8.45B |
| Nov 11, 2026 | LINE | Lineage, Inc. | Baird | Main | Neutral | Neutral | — | — | $43.44 | +24.36% | 8.45B |
| Nov 11, 2026 | LQDA | Liquidia Corporation | Wells Fargo | Main | Equal-Weight | Equal-Weight | Buy | 15 | $47.33 | -18.57% | 2.79B |
| Nov 11, 2026 | LQDA | Liquidia Corporation | Needham | Main | Buy | Buy | Buy | 15 | $47.33 | -18.57% | 2.79B |
| Nov 11, 2026 | LSTR | Landstar System, Inc. | Morgan Stanley | Main | Underweight | Underweight | Hold | 22 | $131.29 | -11.30% | 5.11B |
| Nov 11, 2026 | LTRX | Lantronix, Inc. | Canaccord Genuity | Main | Buy | Buy | — | — | $6.75 | +50.67% | 259.09M |
| Nov 11, 2026 | LUXE | LuxExperience B.V. | TD Cowen | Main | Buy | Buy | — | — | $9.00 | -15.09% | 1.06B |
| Nov 11, 2026 | MA | Mastercard Incorporated | Bernstein | Main | Outperform | Outperform | Buy | 27 | $663.67 | +1.70% | 505.97B |
| Nov 11, 2026 | MAA | Mid-America Apartment Communities, Inc. | Morgan Stanley | Downgrade | Overweight | Equal-Weight | — | — | $145.00 | +24.41% | 15.57B |
| Nov 11, 2026 | MAA | Mid-America Apartment Communities, Inc. | Evercore ISI Group | Main | In-Line | In-Line | — | — | $145.00 | +24.41% | 15.57B |
